RESMED INC — Director's Dealing 2012

May 16, 2012

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: RESMED INC (RMD)
CIK: 0000943819
Period of Report: 2012-05-14

Reporting Person: QUINN MICHAEL A (Director)

Non-Derivative Transactions

Date	Security	Code	Shares	Price	A/D	Holdings After	Ownership
2012-05-14	ResMed Common Stock	M	12000	$23.095	Acquired	314000	Direct
2012-05-14	ResMed Common Stock	S	12000	$33.3016	Disposed	302000	Direct
2012-05-14	ResMed Common Stock	M	12000	$9.798	Acquired	314000	Direct
2012-05-14	ResMed Common Stock	S	12000	$33.26	Disposed	302000	Direct

Derivative Transactions

Date	Security	Exercise Price	Code	Shares	A/D	Expiration	Underlying	Ownership
2012-05-14	ResMed Common Stock Options	$23.095	M	24000	Disposed	2013-11-10	ResMed Common Stock (24000)	Direct
2012-05-14	ResMed Common Stock Options	$9.7975	M	24000	Disposed	2013-07-07	24,000 (24000)	Direct

Holdings (Non-Derivative)

Security	Shares	Ownership
ASX CDIs	400000	Direct
ResMed Common Stock	6600	Indirect

Footnotes

F1: Represents date options first became exercisable. Options vest 1/12 per month and are fully vested at one year.

F2: Represents date options first became exercisable. Options vest 1/3 annually on the anniversary of the grant.

F3: This transaction was executed in multiple trades at prices ranging from $33.26 and 33.31. The price reported above reflects the weighted average sale price. The reporting person will provide full information regarding the number of shares and prices at which the transaction was effected upon request to the SEC staff, the issuer or the security holder of the issuer.

F4: Previously reported as 40,000 NYSE shares. 1 NYSE share is equal to 10 CDIs.